
About Katherine M. Clark
Katherine M. Clark is a Democratic U.S. Representative from Massachusetts, serving in the House since 2013. She represents the state's 5th congressional district, which includes parts of the Boston suburbs. Clark has held leadership roles within the House Democratic Caucus, including Assistant Speaker, and serves on no committees in the current term.
Clark has disclosed 574 trades with an estimated volume of $9.7 million, making her one of the more active congressional traders. Her top traded stocks include Fidelity Freedom 2025 Fund (FFFEX) with 13 trades, Starbucks (SBUX) with 12, GlaxoSmithKline (GSK) with 12, and Apple (AAPL) with 11. Her sector activity is led by healthcare (68 trades), technology (57), and industrials (56). She has made 261 buys and 310 sells, indicating a slight preference for selling over buying.
Katherine M. Clark's Trades
Trading Activity
| Date | Asset | Type | Amount |
|---|---|---|---|
| 2026-06-16 | UNITED STATES TREAS SER AV-2027; 4.0%; Due 12/15/2027MUNI | buy | $15K-$50K |
| 2026-06-16 | UNITED STATES TREAS SER AV-2027; 4.0%; Due 12/15/2027MUNI | buy | $15K-$50K |
| 2026-06-16 | UNITED STATES TREAS SER AK-2028; 4.25%; Due 02/15/2028MUNI | buy | $50K-$100K |
| 2026-06-16 | UNITED STATES TREAS SER AK-2028; 4.25%; Due 02/15/2028MUNI | buy | $15K-$50K |
| 2026-06-16 | UNITED STATES TREAS SER AJ-2028; 4.25%; Due 01/15/2028MUNI | buy | $15K-$50K |
| 2026-06-16 | UNITED STATES TREAS SER AJ-2028; 4.25%; Due 01/15/2028MUNI | buy | $50K-$100K |
| 2026-06-16 | UNITED STATES TREAS SER AF-2027; 4.125%; Due 10/31/2027MUNI | buy | $50K-$100K |
| 2026-06-16 | UNITED STATES TREAS SER AF-2027; 4.125%; Due 10/31/2027MUNI | buy | $15K-$50K |
| 2025-10-27 | UNITED STATES TREAS SER AU-2026; 4.625%; 11/15/2026 NTS NOTEFUND | buy | $250K-$500K |
| 2025-10-27 | UNITED STATES TREAS SER AU-2026; 4.625%; 11/15/2026 NTS NOTEFUND | buy | $100K-$250K |
| 2025-10-27 | UNITED STATES TREAS SER AU-2026; 4.625%; 11/15/2026 NTS NOTEFUND | buy | $100K-$250K |
| 2025-10-27 | UNITED STATES TREAS SER AU-2026; 4.625%; 11/15/2026 NTS NOTEFUND | buy | $250K-$500K |
| 2025-10-02 | FDGKX | buy | $1K-$15K |
| 2025-10-02 | FSLEX | buy | $1K-$15K |
| 2025-09-17 | PG | sell | $15K-$50K |
| 2025-09-17 | PG | sell | $15K-$50K |
| 2025-08-05 | FFFEX | buy | $1K-$15K |
| 2025-07-02 | FFFEX | buy | $1K-$15K |
| 2025-05-11 | FFFEX | buy | $1K-$15K |
| 2025-05-09 | FFFEX | buy | $1K-$15K |
| 2025-05-08 | FFFEX | buy | $1K-$15K |
| 2025-05-03 | FFFEX | buy | $1K-$15K |
| 2025-05-03 | FDGKX | buy | $1K-$15K |
| 2025-05-03 | FSLEX | buy | $1K-$15K |
| 2025-04-06 | FFFEX | buy | $1K-$15K |
| 2025-03-12 | FFFEX | buy | $1K-$15K |
| 2025-03-01 | FFFEX | buy | $1K-$15K |
| 2025-02-10 | FFFEX | buy | $1K-$15K |
| 2025-02-06 | FFFEX | sell | $1K-$15K |
| 2025-02-06 | HACAX | buy | $1K-$15K |
| 2025-02-04 | FFFEX | buy | $1K-$15K |
| 2025-02-04 | FDGKX | buy | $1K-$15K |
| 2025-02-04 | FSLEX | buy | $1K-$15K |
| 2025-01-07 | FFFEX | buy | $1K-$15K |
| 2024-03-01 | NYCB | sell | $1K-$15K |
| 2024-03-01 | NYCB | sell | $1K-$15K |
| 2024-02-16 | United States Treasury NotesFUND | buy | $100K-$250K |
| 2024-02-16 | United States Treasury NotesFUND | buy | $100K-$250K |
| 2024-01-31 | Ruane, Cunniff, & Goldfarb Inc.OTHE | sell | $100K-$250K |
| 2024-01-23 | United States Treasury NotesFUND | buy | $100K-$250K |
| 2023-10-24 | United States Treasury NotesFUND | buy | $250K-$500K |
| 2023-10-24 | United States Treasury NotesFUND | buy | $250K-$500K |
| 2023-10-09 | KO | sell | $15K-$50K |
| 2023-02-23 | Federal Farm Credit Banks BondFUND | buy | $100K-$250K |
| 2022-09-15 | NTAP | sell | $1K-$15K |
| 2022-07-07 | KB Home Sr Nt 7.500%OTHE | sell | $1K-$15K |
| 2022-04-08 | WBD | exchange | $1K-$15K |
| 2022-04-08 | WBD | exchange | $1K-$15K |
| 2022-04-05 | United States Treasury NotesFUND | buy | $100K-$250K |
| 2022-03-31 | United States Treasury NotesFUND | buy | $100K-$250K |
Estimated current holdings
Derived from disclosed buys minus sells at range midpoints. Positions opened before disclosure records began, or reported only in ranges, make this an estimate of direction and scale, not a brokerage statement.